1520 Route 55, Unit 16, Lagrangeville, NY 12540 | Phone: (845) 447-1343 | Fax: (845) 384-1115 | Mon-Fri 9:00am - 7:00pm | Sat 9:00am - 5:00pm | Sun Closed
Slide background Birthday, Anniversary or Special Celebration?

We've got a card for that!
Slide background Stay Healthy
We're here to help!
Patient Resources
Slide background We want your family happy and healthy!
Call us today to schedule your vaccination!
Your health is our priority.

We take our role in your health very seriously. Come in today to see how we can help.

Where patients come first!

Recent health news and videos.

Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.

10 Aug

Even Light Exercise May Lower Stroke Risk for People With AFib

A new study of more than 87,000 adults found that any level of physical activity — even light activity — was linked to a lower risk of stroke and death in people with and without atrial fibrillation.

07 Aug

Can Yoga Calm an Irritable Gut?

A review of 10 published studies suggests yoga may help reduce digestive symptoms, anxiety and depression in people with irritable bowel syndrome.

06 Aug

Staying Dementia-Free May Depend on These 3 Health Factors in Midlife

A long-term study found that adults with normal blood pressure, no diabetes, and who didn't smoke during middle age lived nearly 13 more years without dementia than those with all three risk factors.

Jalapeño Recall Reaches Seven Grocery Chains In 26 States

Ellyn Vohnoutka HealthDay Reporter August 10, 2026

Jalapeño Recall Reaches Seven Grocery Chains In 26 States

Prepared foods sold at some Trader Joe's, Target, Walmart, Hannaford, Kroger, Stop and Shop and Whole Foods stores are being pulled from shelves because the jalapeños they contain may carry Salmonella.

Taylor Fresh Foods of Salinas, California, announced the voluntary recall Sunday after learning that its pepper supplier wa... Full Page

New Melanoma Drug Based On Herpes Virus Granted FDA Accelerated Approval

Haley Neff HealthDay Reporter August 10, 2026

New Melanoma Drug Based On Herpes Virus Granted FDA Accelerated Approval

Federal regulators have granted accelerated approval to a novel therapy for advanced melanoma — giving doctors another weapon to fight this challenging skin cancer.

Tudriqev is an oncolytic viral therapy, which means it is a virus that targets cancer cells. For this new targeted therapy, scientists trained the herpes simplex virus to... Full Page

Working At Home Makes Breastfeeding Harder, Not Easier, Study Says

Dennis Thompson HealthDay Reporter August 10, 2026

Working At Home Makes Breastfeeding Harder, Not Easier, Study Says

Working from home won’t necessarily help a new mother breastfeed, a new study says.

Mothers who worked from home had lower breastfeeding rates than those working outside the home, researchers reported recently in the Western Journal of Nursing Research.

Surprisingly, stay-at-home moms reported the lowest rates of exclu... Full Page

Even Light Exercise May Lower Stroke Risk For People With A-fib

HealthDay Staff HealthDay Reporter August 10, 2026

Even Light Exercise May Lower Stroke Risk For People With A-fib

If you have atrial fibrillation, or A-fib, getting moving may make a real difference.

A-fib is an irregular heartbeat that raises the risk of stroke — and it affects an estimated 10.5 million adults in the U.S. Yet research shows that people with A-fib tend to be less active than the general population.

A new study of more than... Full Page

Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's

Dennis Thompson HealthDay Reporter August 10, 2026

Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's

Heart health appears to affect brain health among people with a genetic risk for Alzheimer’s disease, a new study says. 

People whose hearts are pumping blood less effectively tend to have brains that are shrinking faster, researchers recently reported in Alzheimer's & Dementia: The Journal of the Alzheimer's Association... Full Page

Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics

Dennis Thompson HealthDay Reporter August 10, 2026

Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics

The weight loss drug Zepbound might cut the risk of heart attack or stroke among type 2 diabetics with excess weight and heart problems, a new study says.

Patients taking tirzepatide (Zepbound/Mounjaro) had a 32% lower risk of heart attack, stroke or death from any cause compared to those taking another diabetes drug, researchers reported ... Full Page

HealthDay
Health News is provided as a service to Lagrange Pharmacy site users by HealthDay. Lagrange Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.

Our Affiliations